Role of Food Intolerance and Protease on Pathophysiology of Irritable Bowel Syndrome
Description: Our aims were to determine whether camostat mesilate (600mg/day), a synthetic protease inhibitor, changes visceral pain sensitivity and gastrointestinal motility and whether these changes affect clinical symptom severity in patients with irritable bowel syndrome (IBS). As a result, camostat mesilate has no effect on visceral sensitivity, colonic motility or serum cytokines compared with placebo in IBS patients.
Amount: ¥4,420,000
Funding type: research
Funder scheme: Grant-in-Aid for Scientific Research (C)
Investigator: Motoyori KANAZAWA
Institution: Tohoku University
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 20
Funder award ID: 20590693
OpenAlex ID: G195668985
